Evidence map›Paper›PMID 35363775›Full record

ArticlePloS one2022

Group B Streptococcus colonization at delivery is associated with maternal peripartum infection.

Anne Karin Brigtsen, Anne Flem Jacobsen, Lumnije Dedi, Kjetil Klaveness Melby, Cathrine Nygaard Espeland, Drude Fugelseth, Andrew Whitelaw

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Article
  3. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  4. Serotype Prevalence of Group BInternational journal of fertility & sterility · 2026
    Article
  5. Article
  6. Re-framing the importance of Group BInfection and immunity · 2024
    Review
  7. Article
  8. Colonisation of Group BBMJ open · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Anne Karin BrigtsenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.ORCID 0000-0002-0904-0426
Anne Flem JacobsenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Lumnije DediDepartment of Microbiology, Oslo University Hospital Ullevål, Oslo, Norway.
Kjetil Klaveness MelbyInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Cathrine Nygaard EspelandDepartment of Neonatal Intensive Care, Oslo University Hospital Ullevål, Oslo, Norway.
Drude FugelsethInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Andrew WhitelawInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGroup B Streptococcus (GBS) is a major cause of serious neonatal infection but its role in maternal morbidity has received little investigation. The aim of this study was to determine whether GBS colonization at delivery is associated with increased risk of maternal peripartum infection.

methodsIn this prospective cohort study, 1746 unselected women had a vaginal-rectal culture taken at the onset of labor. Diagnosis of maternal peripartum infection was based on a combination of two or more signs or symptoms including fever, breast pain, severe wound or pelvic pain, purulent discharge and abnormal laboratory tests including C-reactive protein and white blood cell count occurring from labor until 2 weeks postpartum. The main outcome measure was the proportion of women with maternal peripartum infection according to GBS colonization status.

resultsA total of 25.9% (452/1746) women were colonized with GBS. The rate of peripartum infection was almost twice as high in colonized women (49/452 [10.8%]) vs. non-colonized women (81/1294 [6.3%]); OR 1.82 [1.26-2.64], p = 0.002). This association was confirmed in a multivariable model (OR 1.99 [1.35-2.95], p = 0.001). Women diagnosed with peripartum infection had a significantly longer hospital stay compared to women without peripartum infection (4 days (median) vs. 3 days, p < 0.001). Length of hospital stay did not differ between colonized and non-colonized women. Serotype IV GBS was more frequent in colonized women with peripartum infection than in women without peripartum infection (29.3% vs. 12.5%, p = 0.003).

conclusionsGBS colonization at delivery is associated with increased risk of peripartum infection. Whether this increase is due directly to invasion by GBS or whether GBS colonization is associated with a more general vulnerability to infection remains to be determined.

Indexed as

Pregnancy Complications, InfectiousStreptococcal InfectionsFemaleHumansInfant, NewbornPeripartum PeriodPregnancyProspective StudiesRectumStreptococcus agalactiaeVagina

Identifiers

PMID35363775
PMCPMC8975154
OpenAlexW4220988588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.